Brooks Laboratories Ltd BROOKS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹91.74
- Day Range
- ₹91.80–94.00
- 52-Week Range
- ₹73.25–179.95
- Bid/Ask
- ₹92.12 / ₹92.12
- Market Cap
- ₹2.42 Bil
- Volume/Avg
- 72,886 / 53,146
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.96
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. It has manufacturing sites located in Baddi, Himachal Pradesh, and Vadodara, Gujarat. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 296
- Website
- https://www.brookslabs.net
Valuation
|
Metric
|
BROOKS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 3.69 |
Price/Sales | 2.96 |
Price/Cash Flow | 90.68 |
Price/Earnings
BROOKS
Financial Strength
|
Metric
|
BROOKS
|
|---|---|
Quick Ratio | 0.81 |
Current Ratio | 1.35 |
Interest Coverage | −22.16 |
Quick Ratio
BROOKS
Profitability
|
Metric
|
BROOKS
|
|---|---|
Return on Assets (Normalized) | −19.22% |
Return on Equity (Normalized) | −26.91% |
Return on Invested Capital (Normalized) | −24.28% |
Return on Assets
BROOKS
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Jdwrldmjm | Nqzh | $82.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Lddgjknvzk | Jtwpltd | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Rfjytvb | Dbn | $41.4 Bil | |||
| Viatris Inc
VTRS
| Ntqryhm | Gcys | $14.4 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Jpgjpxbvb | Tpwd | $13.7 Bil | |||
| Catalent Inc
CTLT
| Bzgwtylz | Chbspb | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Hpczhxql | Gyfs | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Sdqzwmzd | Zmzfn | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Jbhtsllrw | Mtyt | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Bxzsnttnv | Vvbk | $2.7 Bil |